InvestorNewsBreaks – Monogram Technologies Inc. (NASDAQ: MGRM) Secures Indian Regulatory Approval for Robotic Knee Surgery Clinical Trial
Monogram Technologies (NASDAQ: MGRM), an AI-driven robotics company transforming orthopedic surgery, has received approval from India’s Central Drugs Standard Control Organization to import its mBôs TKA system and begin a 102-patient, multi-center clinical trial in partnership with Shalby Limited (NSE: SHALBY). The study will evaluate the safety and effectiveness of Monogram’s robotic total knee replacement system using a Consensus CKS implant and include three-month clinical…